Home » Shop » hot sale » Human ARL2BP Protein

Human ARL2BP Protein

Original price was: $119.20.Current price is: $81.87.

Sale!
SKU: PW14836851393 Category:

Human ARL2BP Protein

Catalog number: B2011770
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 g
Molecular Weight or Concentration: 1 mg/mL
Supplied as: Solution
Applications: molecular tool for various biochemical applications
Storage: -20 C
Keywords: ARL2BP, ARLBP 2 protein, ARLBP-2 protein, BART protein, ADP-ribosylation factor-like 2 binding protein protein, ARLBP 2, BART1, ARLBP-2
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Fahim AT, Daiger SP, Weleber RG. Nonsyndromic Retinitis Pigmentosa Overview 2000 Aug 4 [updated 2017 Jan 19]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews() [Internet]. Seattle (WA): University of Washington, Seattle; 19932022.
  • Moye AR, Bedoni N, Cunningham JG, Sanzhaeva U, Tucker ES, Mathers P, Peter VG, Quinodoz M, Paris LP, Coutinho-Santos L, Camacho P, Purcell MG, Winkelmann AC, Foster JA, Pugacheva EN, Rivolta C, Ramamurthy V. Mutations in ARL2BP, a protein required for ciliary microtubule structure, cause syndromic male infertility in humans and mice PLoS Genet. 2019 Aug 19;15(8):e1008315.
  • Davidson AE, Schwarz N, Zelinger L, Stern-Schneider G, Shoemark A, Spitzbarth B, Gross M, Laxer U, Sosna J, Sergouniotis PI, Waseem NH, Wilson R, Kahn RA, Plagnol V, Wolfrum U, Banin E, Hardcastle AJ, Cheetham ME, Sharon D, Webster AR. Mutations in ARL2BP, encoding ADP-ribosylation-factor-like 2 binding protein, cause autosomal-recessive retinitis pigmentosa Am J Hum Genet. 2013 Aug 8;93(2):321-9.
  • Wright ZC, Loskutov Y, Murphy D, Stoilov P, Pugacheva E, Goldberg AFX, Ramamurthy V. ADP-Ribosylation Factor-Like 2 (ARL2) regulates cilia stability and development of outer segments in rod photoreceptor neurons Sci Rep. 2018 Nov 16;8(1):16967.
  • Fiorentino A, Yu J, Arno G, Pontikos N, Halford S, Broadgate S, Michaelides M, Carss KJ, Raymond FL, Cheetham ME, Webster AR, Downes SM, Hardcastle AJ; NIHR-BioResource Rare Diseases Consortium; U.K. Inherited Retinal Dystrophy Consortium. Novel homozygous splicing mutations in ARL2BP cause autosomal recessive retinitis pigmentosa Mol Vis. 2018 Aug 31;24:603-612. eCollection 2018.
  • ElMaghloob Y, Sot B, McIlwraith MJ, Garcia E, Yelland T, Ismail S. ARL3 activation requires the co-GEF BART and effector-mediated turnover Elife. 2021 Jan 13;10:e64624.
  • Cai XB, Wu KC, Zhang X, Lv JN, Jin GH, Xiang L, Chen J, Huang XF, Pan D, Lu B, Lu F, Qu J, Jin ZB. Whole-exome sequencing identified ARL2 as a novel candidate gene for MRCS (microcornea, rod-cone dystrophy, cataract, and posterior staphyloma) syndrome Clin Genet. 2019 Jul;96(1):61-71.
  • Audo I, El Shamieh S, Mjcase C, Michiels C, Demontant V, Antonio A, Condroyer C, Boyard F, Letexier M, Saraiva JP, Blanchard S, Mohand-Sad S, Sahel JA, Zeitz C. ARL2BP mutations account for 0.1% of autosomal recessive rod-cone dystrophies with the report of a novel splice variant Clin Genet. 2017 Jul;92(1):109-111.
  • Morales-Sanchez A, Fuentes-Panana EM. Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Oncogenesis Curr Cancer Drug Targets. 2017;17(6):534-554.